88.67
Healthequity Inc stock is traded at $88.67, with a volume of 769.97K.
It is up +3.07% in the last 24 hours and up +7.31% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$86.03
Open:
$87.32
24h Volume:
769.97K
Relative Volume:
0.78
Market Cap:
$7.41B
Revenue:
$1.31B
Net Income/Loss:
$215.20M
P/E Ratio:
36.01
EPS:
2.4627
Net Cash Flow:
$408.32M
1W Performance:
+0.77%
1M Performance:
+7.31%
6M Performance:
-6.18%
1Y Performance:
-21.32%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, BTSG, TEM, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
88.67 | 7.19B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
VEEV
Veeva Systems Inc
|
172.61 | 29.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
57.40 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
46.43 | 9.38B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HNGE
Hinge Health Inc
|
63.62 | 4.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
What HealthEquity (HQY)'s Strong Q1, Higher Guidance and Buybacks Mean For Shareholders - simplywall.st
Norges Bank Buys New Shares in HealthEquity, Inc. $HQY - MarketBeat
Number of shareholders of HealthEquity, Inc. – NASDAQ:HQY - TradingView
Cost of goods sold of HealthEquity Inc – XETR:2HE - TradingView
A Quick Look at Today's Ratings for HealthEquity(HQY.US), With a Forecast Between $108 to $125 - Moomoo
ETFs Investing in HealthEquity Inc Stocks - TradingView
Asset turnover of HealthEquity Inc – XETR:2HE - TradingView
HealthEquity Inc Cash Flow – XETR:2HE - TradingView
HealthEquity Inc Balance Sheet – XETR:2HE - TradingView
HealthEquity Inc Income Statement – XETR:2HE - TradingView
HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen - MarketBeat
Westfield Capital Management Co. LP Raises Position in HealthEquity, Inc. $HQY - MarketBeat
(HQY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY) - Yahoo Finance
Wall Street Analysts See a 33.49% Upside in HealthEquity (HQY): Can the Stock Really Move This High? - Yahoo Finance
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term - Yahoo Finance
HealthEquity announces CTO departure and transition of technology leadership - Investing.com
RBC Capital reiterates HealthEquity stock rating on growth outlook - Investing.com UK
RBC Capital reiterates HealthEquity stock rating on growth outlook By Investing.com - Investing.com South Africa
HealthEquity Inc (HQY) Shares Fall 3.5% -- What GF Score of 92 T - GuruFocus
HQY Reiterated by RBC Capital -- Price Target Maintained at $108 - GuruFocus
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Yahoo Finance
Legal & General Group Plc Lowers Stake in HealthEquity, Inc. $HQY - MarketBeat
Healthequity Insider Sold Shares Worth $298,490, According to a Recent SEC Filing - marketscreener.com
HealthEquity (NASDAQ: HQY) EVP Fiore sells 3,142 shares under 10b5-1 plan - Stock Titan
HealthEquity director Wellborn Gayle Furgurson sells $219,510 in stock By Investing.com - Investing.com Australia
HealthEquity director Wellborn Gayle Furgurson sells $219,510 in stock - Investing.com
Healthequity EVP, general counsel, sells $675,000 in common stock By Investing.com - Investing.com India
Healthequity EVP, general counsel, sells $675,000 in common stock - Investing.com
HealthEquity (HQY) director sells 2,439 shares in 10b5-1 trade - Stock Titan
HealthEquity (NASDAQ: HQY) EVP Ladd sells 7,500 shares in open-market trade - Stock Titan
Deutsche Bank Raises HealthEquity Price Target to $135 From $128, Maintains Buy Rating - Moomoo
HQY Maintained by Citizens -- Price Target Raised to $111.00 - GuruFocus
Citizens raises HealthEquity stock price target to $111 on margin outlook - Investing.com UK
Citizens raises HealthEquity stock price target to $111 on margin outlook By Investing.com - Investing.com South Africa
HealthEquity, Inc. (HQY) Stock Analysis: Exploring A 30% Upside Potential - DirectorsTalk Interviews
HealthEquity, Inc. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
HealthEquity (HQY) Reports Q1 Earnings: What Key Metrics Have to Say - MSN
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN) and Healthequity (HQY) - The Globe and Mail
Analysts’ Top Healthcare Picks: Healthequity (HQY), Teladoc (TDOC) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Healthequity (HQY) - The Globe and Mail
HealthEquity, Inc. $HQY Position Increased by Future Fund LLC - MarketBeat
HealthEquity (HQY) Net Margin Jump To 17.3% Tests Bullish Profitability Narrative - Sahm
HQY Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
HealthEquity Earnings Call Signals Confident Growth Path - TipRanks
UnitedHealthcare sits mid-pack in managed healthcare quant rankings - MSN
[144] HEALTHEQUITY, INC. SEC Filing - Stock Titan
HealthEquity, Inc. Stock 12‑Month Price Target Raised to $114.56, Implies 27% Upside - TradingView
HQY Maintained by RBC Capital -- Price Target Raised to $108 - GuruFocus
How Investors May Respond To HealthEquity (HQY) Upgraded Outlook, AI Efficiencies and Larger Buyback Plan - simplywall.st
HealthEquity (NASDAQ:HQY) Price Target Raised to $108.00 - MarketBeat
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Healthequity Inc Stock (HQY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wellborn Gayle Furgurson | Director |
May 28 '26 |
Option Exercise |
47.21 |
2,439 |
115,145 |
22,172 |
| Wellborn Gayle Furgurson | Director |
May 28 '26 |
Sale |
90.00 |
2,439 |
219,510 |
19,733 |
| Ladd Delano | EVP, General Counsel |
May 28 '26 |
Sale |
90.00 |
7,500 |
675,000 |
91,141 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):